- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07571954
Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy (iNFLOW-5)
Prospective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the Instroke 5F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke.
Prospective, single-arm, multi-centre study to evaluate the efficacy and safety of the iNstroke 5F thromboaspiration catheter in patients with acute ischaemic stroke
연구 개요
상세 설명
This clinical investigation has been designed to evaluate the efficacy and safety of the iNstroke 5F aspiration catheter for its use in the treatment of LVO, with a view to comparing this product with standard therapy or with other similar products in a future pivotal clinical investigation.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Andalusia
-
Málaga, Andalusia, 스페인
- Hospital Regional Universitario de Málaga Carlos Haya
-
연락하다:
- María Teresa Díaz, Dr.
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
수석 연구원:
- María Teresa Díaz, Dr.
-
-
Aragon
-
Zaragoza, Aragon, 스페인
- Hospital Universitario Miguel Servet
-
연락하다:
- María Rosa Barrena
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
수석 연구원:
- María Rosa Barrena, Dr.
-
-
Barcelona
-
Barcelona, Barcelona, 스페인
- Hospital Clínico de Barcelona
-
연락하다:
- Jordi Blasco, Dr
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
수석 연구원:
- Jordi Blasco, Dr.
-
-
Catalonia
-
L'Hospitalet de Llobregat, Catalonia, 스페인
- Hospital Universitario Bellvitge
-
-
Galicia
-
Vigo, Galicia, 스페인
- Hospital Álvaro Cunqueiro
-
연락하다:
- Carlos Manuel Rodriguez, Dr.
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
수석 연구원:
- Carlos Manuel Rodriguez, Dr.
-
-
-
-
-
Bordeaux, 프랑스
- CHU Bordeaux (H Pellegrin)
-
수석 연구원:
- Xavier Barreau, Dr.
-
연락하다:
- Xavier Barreau, Dr
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
Lille, 프랑스
- CHU Lille
-
연락하다:
- Nicolas Bricout
- 전화번호: +34 936724711
- 이메일: clinica@ivascular.global
-
수석 연구원:
- Nicolas Bricout, Dr.
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Subjects aged ≥ 18 years.
- Subjects able to be treated (i.e., defined by groin puncture time) within 24 hours of symptom onset or last time seen well.
- Occlusion in a large or proximal medium vessel (M1, proximal M2, A2 or P2) identified by magnetic resonance angiography (MRA) or computed tomography angiography (CTA).
- Baseline NIHSS score ≥ 6 assessed before the procedure.
- Pre-stroke mRS score ≤ 2.
- Subjects with an ASPECTS score ≥ 6.
- Informed consent obtained in accordance with the applicable country-specific regulations and as approved by the Ethics Committee (EC).
- France-specific inclusion criteria: As applicable under French law, subjects affiliated with a health social security scheme or equivalent.
Exclusion Criteria:
- Severe comorbidity and/or shortened life expectancy that will likely prevent improvement or follow up or that will render the procedure unlikely to benefit the patient.
- Severe allergy to contrast media.
- Women of child-bearing potential.
- Subjects with intracranial atherosclerotic occlusive disease or extra- or intracranial dissection.
- Medical history of thrombocytopenia (Platelets <100,000).
- Subjects with tandem occlusions (evidence of complete occlusion, high-grade stenosis or arterial dissection in the extracranial or petrous segment of the internal carotid artery).
- Subjects with occlusions in multiple vessels.
- Subjects with cancer who have a life expectancy of less than 6 months.
- Pre-existing neurological or psychiatric illness that could confound the neurological or functional assessments.
- Severe sustained hypertension (systolic pressure >185 mm Hg or diastolic pressure >110 mm Hg). Note: If blood pressure can be successfully reduced and maintained at an acceptable level by administering the medication recommended by the ESO (European Stroke Organisation) in its guidelines (also IV infusion of antihypertensives), the subject may be included.
- Known or suspected cerebral vasculitis.
- Known renal insufficiency with creatinine ≥3 mg/dl or Glomerular Filtration Rate (GFR) <30 mL/min.
- Current participation in an interventional drug or device study that may confound the results of this study.
- Intracranial stenosis proximal to the occlusion.
- France-specific exclusion criteria: As applicable under French law, breastfeeding women, persons deprived of their liberty by a judicial or administrative decision, or persons of legal age who are the subject of a legal protection measure.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
다른: Thromboaspiration using iNstroke 5F aspiration catheter
No comparator will be used as this is a traditional feasibility clinical investigation. The objective is to capture preliminary clinical performance, effectiveness and safety information to adequately plan an appropriate pivotal clinical investigation. |
Patients to undergo thromboaspiration with iNstroke 5F |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Recanalization Rate
기간: Intra-procedure
|
Recanalization rate with mTICI ≥2b in ≤3 revascularization passes using iNstroke Thrombus Extraction Aspiration Device aspiration catheter alone, or in conjunction with Stent Retriever |
Intra-procedure
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .